These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7948777)

  • 1. Effect of thrombosis on complement activation and neutrophil degranulation during in vitro hemodialysis.
    Cheung AK; Faezi-Jenkin B; Leypoldt JK
    J Am Soc Nephrol; 1994 Jul; 5(1):110-5. PubMed ID: 7948777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation.
    Böhler J; Schollmeyer P; Dressel B; Dobos G; Hörl WH
    J Am Soc Nephrol; 1996 Feb; 7(2):234-41. PubMed ID: 8785392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of main granulocyte components during hemodialysis. Comparison of new and reused dialyzers.
    Hörl WH; Feinstein EI; Wanner C; Frischmuth N; Gösele A; Massry SG
    Am J Nephrol; 1990; 10(1):53-7. PubMed ID: 2343881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble complement receptor type 1 inhibits complement activation induced by hemodialysis membranes in vitro.
    Cheung AK; Parker CJ; Hohnholt M
    Kidney Int; 1994 Dec; 46(6):1680-7. PubMed ID: 7700027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leukotrienes.
    Böhler J; Donauer J; Birmelin M; Schollmeyer PJ; Hörl WH
    Nephrol Dial Transplant; 1993; 8(12):1359-65. PubMed ID: 8159305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta2 integrins are required for neutrophil degranulation induced by hemodialysis membranes.
    Cheung AK; Parker CJ; Hohnholt M
    Kidney Int; 1993 Mar; 43(3):649-60. PubMed ID: 8455364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation.
    Gabutti L; Ferrari N; Mombelli G; Keller F; Marone C
    J Nephrol; 2004; 17(6):819-25. PubMed ID: 15593057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution.
    Moore FD; Warner KG; Assousa S; Valeri CR; Khuri SF
    Ann Surg; 1988 Jul; 208(1):95-103. PubMed ID: 3260474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenin: a novel inhibitor of neutrophil lactoferrin release during extracorporeal circulation.
    Schmaldienst S; Oberpichler A; Tschesche H; Hörl WH
    Kidney Blood Press Res; 2003; 26(2):107-12. PubMed ID: 12771535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
    Varela MP; Kimmel PL; Phillips TM; Mishkin GJ; Lew SQ; Bosch JP
    Blood Purif; 2001; 19(4):370-9. PubMed ID: 11574733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellulose acetate hemodialysis membranes are better tolerated than Cuprophan. A difference in complement and neutrophil activation.
    Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE
    Contrib Nephrol; 1984; 37():78-82. PubMed ID: 6713881
    [No Abstract]   [Full Text] [Related]  

  • 16. Modified cellulosic dialyzer membranes: an investigative tool in thrombogenicity studies.
    Mahiout A; Meinhold H; Kessel M; Vienken J; Baurmeister U
    ASAIO Trans; 1988; 34(3):878-81. PubMed ID: 3058187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two hemodialysis membranes, polyacrylonitrile and cellulose acetate, on complement and coagulation systems.
    Moll S; De Moerloose P; Reber G; Schifferli J; Leski M
    Int J Artif Organs; 1990 May; 13(5):273-9. PubMed ID: 2142140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of complement activation on hemodialysis membranes by immobilized heparin.
    Cheung AK; Parker CJ; Janatova J; Brynda E
    J Am Soc Nephrol; 1992 Feb; 2(8):1328-37. PubMed ID: 1385732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of r-hirudin vs. heparin on blood-membrane interactions during hemodialysis.
    van Wyk V; Badenhorst PN; Kotzé HF
    Clin Nephrol; 1997 Dec; 48(6):381-7. PubMed ID: 9438098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.